• Sosei Heptares and Genentech enter GPCR target alliance pharmaceutical-technology
    July 18, 2019
    Japanese biopharmaceutical group Sosei Heptares has partnered with Roche subsidiary Genentech for the discovery and development of drugs that modulate G protein-coupled receptor (GPCR) targets.
PharmaSources Customer Service